Friday 6 November 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024.

Revenue: +16.7%
EPS: +747.6%
Free cash flow: −4.76%
Total debt: −2.66%

Quarter to September 2026, against a year earlier

156.01 0.65 −0.41%

Follow ALNY

Alert me

Market cap: $21.0B
P/E: 7.9×
Fwd P/E: 13.5×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	5	7	7	6	+8 more TTM periods Free account
ROE Full definition →	138.07%	96.55%	90.36%	73.28%
ROA Full definition →	41.25%	15.30%	11.52%	6.82%
ROIC Full definition →	59.37%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	72.30%	21.16%	15.88%	10.13%
Average Days of Receivables Full definition →	78.99	69.35	75.26	76.42
Free Cash Flow per Share Full definition →	6.02	6.14	4.84	3.52
Free Cash Flow Full definition →	806.31	819.87	643.34	465.38
Capital Expenditures Full definition →	(149.64)	(91.95)	(71.56)	(58.70)
Other line items
Cash ROIC Full definition →	9.83%	14.45%	12.63%	9.89%
Accounts Receivable Turnover Full definition →	4.89	6.49	6.59	6.28
Accounts Payable Turnover Full definition →	9.00	9.29	7.34	6.68
Inventory Turnover Full definition →	12.57	11.58	10.99	8.46
Average Days of Payables Full definition →	43.39	40.34	56.23	61.94
Days of Inventory on Hand Full definition →	33.94	36.26	37.31	44.28
Tax Rate Full definition →	2.39	0.01	(0.02)	(0.03)
Research and Development Expense of Revenue Full definition →	31.09%	31.41%	33.11%	35.54%
Selling, General and Administrative Expense of Revenue Full definition →	26.69%	27.43%	30.17%	32.60%
Share Based Compensation of Revenue Full definition →	6.13%	7.01%	8.44%	9.38%
Interest Coverage Full definition →	3.25	3.52	2.85	1.99
Operating CF/Net income Full definition →	0.36	1.18	1.33	1.67
Depreciation/Fixed assets Full definition →	0.09	0.10	0.11	0.11
Capex/Depreciation Full definition →	(2.70)	(1.68)	(1.31)	(1.05)
Revenue per Share Full definition →	37.46	35.96	32.26	28.09
Operating CF per Share Full definition →	7.14	6.82	5.38	3.96
Capex per Share Full definition →	(1.12)	(0.69)	(0.54)	(0.44)
Capex to Sales Full definition →	0.03	0.02	0.02	0.02

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly